Duke logo

Varenicline Light Smoking Pilot - Clinical Trial

What is the Purpose of this Study?

We are doing this study to help light smokers quit smoking.

What is the Condition Being Studied?

Smoking

Who Can Participate in the Study?

Adults who:
-Smoke less than 10 cigarettes per day
-Do not take drugs
-Do not drink alcohol heavily
-Have a phone capable of sending and receiving text messages

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
-Be randomly assigned (like flipping a coin) to take either:
---Chantix (Study medicine) OR placebo (harmless medicine) for 6 weeks.
-Complete 5 study visits over 6 weeks
-Complete daily text messages
-Keep a self-report diary every week

Study Details

Full Title
Pilot Study on Varenicline in Light and Intermittent Smokers
Principal Investigator
Internal Medicine Doctor
Protocol Number
IRB:PRO00103506
NCT:NCT04089982
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698